CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+16.29%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$7.82B
AUM Growth
+$1.31B
(+20%)
Cap. Flow
+$157M
Cap. Flow
% of AUM
2.01%
Top 10 Holdings %
Top 10 Hldgs %
19.27%
Holding
875
New
65
Increased
350
Reduced
240
Closed
80
Top Buys
| 1 |
Merck
MRK
|
$46.7M |
| 2 |
Bristol-Myers Squibb
BMY
|
$29.1M |
| 3 |
Gilead Sciences
GILD
|
$27.9M |
| 4 |
BZUN
Baozun
BZUN
|
$26.6M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$26.5M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$81.1M |
| 2 |
Danaher
DHR
|
$31.9M |
| 3 |
LOXO
Loxo Oncology, Inc
LOXO
|
$28.1M |
| 4 |
Agilent Technologies
A
|
$28M |
| 5 |
McCormick & Company Non-Voting
MKC
|
$20.1M |
Sector Composition
| 1 | Healthcare | 33.36% |
| 2 | Technology | 16% |
| 3 | Financials | 11.25% |
| 4 | Consumer Discretionary | 8.98% |
| 5 | Communication Services | 7.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
UnitedHealth
UNH
$280B
| $50.3M | 0.64% |
203,332
-8,966
| -4% | -$2.22M |
|
27
AT&T
T
$211B
| $49.4M | 0.63% |
1,909,585
+26,059
| +1% | +$675K |
|
28
PepsiCo
PEP
$201B
| $48M | 0.61% |
365,068
+177,049
| +94% | +$23.3M |
|
29
Oracle
ORCL
$623B
| $46.5M | 0.6% |
842,543
+33,300
| +4% | +$1.84M |
|
30
AbbVie
ABBV
$375B
| $45.7M | 0.58% |
566,513
+19,159
| +4% | +$1.54M |
|
31
Berkshire Hathaway Class B
BRK.B
$1.09T
| $45.6M | 0.58% |
192,880
-17,439
| -8% | -$4.12M |
|
32
Abbott
ABT
$233B
| $45.2M | 0.58% |
565,751
-46,893
| -8% | -$3.75M |
|
|
33
Alphabet (Google) Class C
GOOG
$2.76T
| $45.1M | 0.58% |
769,100
+76,160
| +11% | +$4.47M |
|
34
TSMC
TSM
$1.21T
| $44.5M | 0.57% |
1,085,505
+499,819
| +85% | +$20.5M |
|
35
PayPal
PYPL
$65.1B
| $43.3M | 0.55% |
417,026
-62,295
| -13% | -$6.47M |
|
36
Salesforce
CRM
$231B
| $43M | 0.55% |
271,420
-1,884
| -0.7% | -$298K |
|
37
Incyte
INCY
$16.8B
| $42.5M | 0.54% |
493,935
+28,413
| +6% | +$2.44M |
|
38
Citigroup
C
$177B
| $42.1M | 0.54% |
623,099
+43,554
| +8% | +$2.94M |
|
39
American Express
AXP
$229B
| $41.6M | 0.53% |
368,832
+6,824
| +2% | +$770K |
|
40
JPMorgan Chase
JPM
$833B
| $41.6M | 0.53% |
411,010
-99,686
| -20% | -$10.1M |
|
41
BioMarin Pharmaceuticals
BMRN
$10.9B
| $40.9M | 0.52% |
459,852
| – | – |
|
|
ARRY
42
DELISTED
Array Biopharma Inc
ARRY
| $39.1M | 0.5% |
1,605,480
-73,230
| -4% | -$1.79M |
|
43
Rockwell Automation
ROK
$38.3B
| $39.1M | 0.5% |
222,553
+14,805
| +7% | +$2.6M |
|
44
Emerson Electric
EMR
$73.9B
| $37.4M | 0.48% |
545,699
+211,102
| +63% | +$14.5M |
|
45
Broadcom
AVGO
$1.43T
| $37.2M | 0.48% |
1,235,640
-10,200
| -0.8% | -$307K |
|
46
TAL Education Group
TAL
$6.27B
| $34.9M | 0.45% |
966,000
+423,000
| +78% | +$15.3M |
|
47
Mastercard
MA
$536B
| $34.2M | 0.44% |
145,370
-15,057
| -9% | -$3.55M |
|
48
Intel
INTC
$106B
| $32.6M | 0.42% |
564,891
-261,919
| -32% | -$15.1M |
|
49
Ionis Pharmaceuticals
IONS
$9.44B
| $31.9M | 0.41% |
393,200
+144,000
| +58% | +$11.7M |
|
|
AERI
50
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $28.7M | 0.37% |
604,800
+126,000
| +26% | +$5.99M |
|